Tag: IPO
Capital Markets Crystal Ball: Predictions for 2026
By Liz Dunshee With New Year’s Day approaching, now is an exciting time to imagine what lies ahead for the capital markets. Q1 is typically quiet, but if you’re considering an initial public offering in 2026, keep an eye out for these key signs of a healthy market, drawn from […]
Thursday’s Webcast: “What to Expect From the SEC Now That the Government Shutdown Has Ended”
By Liz Dunshee In the wake of the lengthiest government shutdown in history, questions remain about how the Securities and Exchange Commission staff is tackling its backlog of registration statements – and the potential impact on the SEC’s enforcement, rulemaking and disclosure review priorities. Tune in this Thursday, December 4, […]
CapitalXchange Audio – Hong Kong IPOs With Will Cai
By Liz Dunshee Team Cooley has guided issuers and banks through pricing 12 Hong Kong IPOs so far this year! With a robust Chapter 18C pipeline, we expect more to come. In this CapitalXchange audio blog, I caught up with Will Cai to learn more about these deals. Will co-chairs […]
Nasdaq Revisits Listing Requirements (Again): Proposing Stricter Criteria for New and Continued Listings
By Liz Dunshee As I mentioned in Part 1 of this blog, recent proposals and commentary from Nasdaq show that the exchange is focused on encouraging capital formation. That post addressed Nasdaq’s efforts to modernize market infrastructure and make it easier to be a public company. This post discusses proposals […]
Past Event: 2020 TechGC SPAC Forum
SPACs and Direct Listings have emerged as a significant new liquidity path for high growth tech companies over the last several months. In this three-day virtual forum, we’ll discuss how to approach these liquidity events strategically including evaluating which structure to use, understanding economics / dilution, and how to execute […]
Past Event: Deloitte IPO Bootcamp 2020
Should you IPO? Timing the market can be difficult so it’s important to prepare your company well in advance of your targeted offering date. This exclusive workshop designed for C-suite executives, accounting and finance leaders of pre-IPO companies will offer actionable insights and best practices for a successful IPO. This […]
A Couple of Quick Items Regarding IPO Alternatives
Here are two quick items regarding popular IPO alternatives, SPACs (special purpose acquisition corporations) and primary direct listings: SPACs. In an interview on CNBC with Andrew Ross Sorkin on Thursday, SEC Chair Jay Clayton addressed the recent SPAC frenzy. (Very loosely, SPACs are companies with no real operations formed to […]
Past Event: Cell & Gene Meeting on The Mesa
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. This conference covers commercialization hurdles facing the cell and gene therapy sector as well as a wide range of topics […]
Past Event: Bay Area IPO Readiness Workshop
Cooley partner Dave Peinsipp, Deloitte and leaders from other organizations well-versed in the IPO, direct listing and SPAC processes shared their insights on the next normal. Topics include Current market conditions Regulatory considerations How to prepare for the IPO process Life as a public company Actionable insights from a CFO/controller […]
Past Event: The 2020 IPO Comeback Series
After IPO issuances came to a near-halt in late Q1 and early Q2 2020, the window reopened wide this summer when much-needed liquidity infused the markets and led to one of the strongest months for IPOs in 13 years. This two-part executive webinar series was on the novel challenges of […]